15-63277724-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_031301.4(APH1B):āc.101T>Gā(p.Phe34Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,610,684 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 29)
Exomes š: 0.000021 ( 0 hom. )
Consequence
APH1B
NM_031301.4 missense
NM_031301.4 missense
Scores
1
13
5
Clinical Significance
Conservation
PhyloP100: 5.75
Genes affected
APH1B (HGNC:24080): (aph-1 homolog B, gamma-secretase subunit) This gene encodes a multi-pass transmembrane protein that is a functional component of the gamma-secretase complex, which also contains presenilin and nicastrin. This protein represents a stabilizing cofactor for the presenilin holoprotein in the complex. The gamma-secretase complex catalyzes the cleavage of integral proteins such as notch receptors and beta-amyloid precursor protein. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 31 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APH1B | NM_031301.4 | c.101T>G | p.Phe34Cys | missense_variant | 1/6 | ENST00000261879.10 | NP_112591.2 | |
APH1B | NM_001145646.2 | c.101T>G | p.Phe34Cys | missense_variant | 1/5 | NP_001139118.1 | ||
APH1B | XM_011522105.4 | c.101T>G | p.Phe34Cys | missense_variant | 1/6 | XP_011520407.1 | ||
APH1B | XR_007064490.1 | n.120T>G | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APH1B | ENST00000261879.10 | c.101T>G | p.Phe34Cys | missense_variant | 1/6 | 1 | NM_031301.4 | ENSP00000261879.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151810Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
4
AN:
151810
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000932 AC: 23AN: 246804Hom.: 0 AF XY: 0.0000523 AC XY: 7AN XY: 133952
GnomAD3 exomes
AF:
AC:
23
AN:
246804
Hom.:
AF XY:
AC XY:
7
AN XY:
133952
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1458874Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 725874
GnomAD4 exome
AF:
AC:
31
AN:
1458874
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
725874
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151810Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 74114
GnomAD4 genome
AF:
AC:
4
AN:
151810
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
74114
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.101T>G (p.F34C) alteration is located in exon 1 (coding exon 1) of the APH1B gene. This alteration results from a T to G substitution at nucleotide position 101, causing the phenylalanine (F) at amino acid position 34 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
DEOGEN2
Uncertain
D;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Gain of catalytic residue at L35 (P = 0.0272);Gain of catalytic residue at L35 (P = 0.0272);Gain of catalytic residue at L35 (P = 0.0272);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at